Physicochemical stability of phospholipid-dispersed suspensions of crystalline itraconazole

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 3, 2008, Pages 1104-1113

  Werling, Jane ^a   Graham, Sabine ^a   Owen, Heather ^a   Nair, Lakshmy ^a   Gonyon, Thomas ^a   Carter, Phillip W ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Crystalline suspensions; Hydrolysis; Itraconazole; Oleate; Phospholipid; Physicochemical stability

Indexed keywords

FATTY ACID; ITRACONAZOLE; LIPID; OLEATE SODIUM; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ARTICLE; CRYSTAL; DISPERSION; DRUG STABILITY; HYDROLYSIS; PARTICLE SIZE; PH; SUSPENSION; ZETA POTENTIAL;

ANTIFUNGAL AGENTS; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; DRUG STABILITY; ELECTROCHEMISTRY; EXCIPIENTS; FATTY ACIDS, NONESTERIFIED; HYDROGEN-ION CONCENTRATION; ITRACONAZOLE; LECITHINS; PARTICLE SIZE; PHOSPHOLIPIDS; SUSPENSIONS;

EID: 48149106757     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.01.030     Document Type: Article

References (33)

1. Brown R., Querica R.A., and Sigman R. Total nutrient admixture: a review. JPEN 10 (1986) 650-658
2. Yamaguchi T. Lipid microspheres as drug carriers: a pharmaceutical point of view. Adv. Drug. Del. Rev. 20 (1996) 117-130
3. Trotta M., Pattarino F., and Ignoni T. Stability of drug-carrier emulsions containing phosphatidylcholine mixtures. Eur. J. Pharm. Biopharm. 53 (2002) 203-208
4. Washington C. Stability of lipid emulsions for drug delivery. Adv. Drug Del. Rev. 20 (1996) 131-145
5. Mohammed A.R., Weston N., Coombes A.G.A., Fitzgerald M., and Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int. J. Pharm. 285 (2004) 23-34
6. Maitani Y., Nakagaki M., and Nagai T. Surface potential of liposomes with entrapped insulin. Int. J. Pharm. 64 (1990) 89-98
7. Kogan A., and Garti N. Microemulsiions as transdermal drug delivery vehicles. Adv. Coll. Interface Sci. 123-126 (2006) 369-385
8. Muller R.H., Mader K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
9. Perkins W.R., et al. Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds. Int. J. Pharm. 200 (2000) 27-39
10. Pace S.N., Pace G.W., Parikh I., and Mishra A.K. Novel Injectable Formulations of Insoluble Drugs. Pharm. Techn. 23:33 (1999) 116-134
11. Young T.J., Johnston K.P., Pace G.W., and Mishra A.K. Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech 5 (2003) 1-16 Article 11
12. Chaubal M.V., Kipp J., and Rabinow B. Excipient development for pharmaceutical biotechnology and drug delivery systems. Informa Healthcare (2006) 271-290
13. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18 (2003) 113-120
14. Duro R., Souto C., Gomez-Amoza J.L., Pacheco R.M., and Concheiro A. Interfacial adsorption of polymers and surfactants: implications for the properties of disperse systems of pharmaceutical interest. Drug Dev. Ind. Pharm. 25 (1999) 817-829
15. Grit M., and Crommelin D.J.A. Chemical stability of liposomes: implications for their physical stability. Chem. Phys. Lipids 64 (1993) 3-18
16. Hakansson I. Physico-chemical changes in artificial fat emulsions during storage. Acta Chem. Scand. 20 (1966) 2267-2281
17. Grit M., Underberg W.J.M., and Crommelin D.J.A. Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J. Pharm. Sci. 82 (1993) 362-366
18. Chansiri G., Lyons R.T., Patel M.V., and Hem S.L. Effect of surface charge on the stability of oil/water emulsions during steam sterilization. J. Pharm. Sci. 88 (1999) 454-458
19. Herman C.J., and Groves M.J. The influence of free fatty acid formation on the pH of phospholipid stabilized triglyceride emulsions. Pharm. Res. 10 (1993) 774-776
20. Buszello K., Harnisch S., Muller R.H., and Muller B.W. The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with Solutol HS 15. Eur. J. Pharm. Biopharm. 49 (2000) 143-149
21. Zuidam N.J., Gouw H.K.M.E., Barenholz Y., and Crommelin D.J.A. Physical (in)stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. Biochim. Biophys. Acta 1240 (1995) 101-110
22. Rabinovich-Guilatt L., Dubernet C., Gaudin K., Lambert G., Couvreur P., and Chaminade P. Phospholipid hydrolysis in a pharmaceutical emulsion assessed by physicochemical parameters and a new analytical method. Eur. J. Pharm. 61 (2005) 69-76
23. Rubino J.T. The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions I: kinetic assessment of emulsion stability. J. Parent. Sci. Tech. 44 (1990) 210-215
24. Groves M.J., and Herman C.J. The redistribution of bulk aqueous phase phospholipids during thermal stressing of phospholipid-stabilized emulsions. J. Pharm. Pharmacol. 45 (1993) 592-596
25. Grit M., and Crommelin D.J.A. The effect of aging on the physical stability of liposome dispersions. Chem. Phys. Lipids 62 (1992) 113-122
26. Zuidam N.J., and Crommelin D.J.A. Differential scanning calorimetric analysis of dipalmitoylphosphatidylcholine-liposomes upon hydrolysis. Int. J. Pharm. 126 (1995) 209-217
27. Washington C., and Davis S.S. Ageing effects in parenteral fat emulsions: the role of fatty acids. Int. J. Pharm. 39 (1987) 33-37
28. Han J., Davis S.S., Papandreou C., Melia C.D., and Washington C. Design and evaluation of an emulsion vehicle for paclitaxel I. Physicochemical properties and plasma stability. Pharm. Res. 21 (2004) 1573-1580
29. Cistola D.P., Hamilton J.A., Jackson D., and Small D.M. Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule. Biochemistry 27 (1988) 1881-1888
30. Langner M., Isac T., and Hui S.W. Interaction of free fatty acids with phospholipid bilayers. Biochim. Biophys. Acta 1236 (1995) 73-80
31. Rabinow B., et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int. J. Pharm. 339 (2007) 251-260
32. Kuch A., and Saari-Nordhaus R. Dual-mode ELSD: optimum performance for a wide range of applications. Am. Lab. 33 (2001) 61-64
33. Wong J., Brugger A., Khare A., Chaubal M., Papadopoulos P., Rabinow B., Kipp J., and Ning J. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv. Drug Deliv. Rev. (2008) 10.1016/j.addr.2007.11.008